Trametinib and Navitoclax in Treating Patients With Advanced or Metastatic Solid Tumors

This study has suspended participant recruitment.
(Drug supply issues)
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT02079740
First received: March 4, 2014
Last updated: July 21, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: September 2017 (Final data collection date for primary outcome measure)